Related Experiment Video
Updated: Nov 16, 2025

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
Risk of ocular hypertension in children treated with systemic glucocorticoid
Susanne Krag1, Dorte Larsen1, Birgitte Klug Albertsen2
1Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark.
Insights
Systemic glucocorticoid treatment in children can cause ocular hypertension. Monitoring intraocular pressure is recommended, as younger children may face a higher risk of steroid-induced eye pressure increases.
Area of Science:
- Pediatric Ophthalmology
- Endocrinology
- Pharmacology
Background:
- Systemic glucocorticoids are widely used in pediatric care.
- Potential side effects include ocular hypertension, a condition characterized by elevated intraocular pressure.
- Understanding this risk is crucial for patient safety and monitoring.
Purpose of the Study:
- To investigate the incidence and characteristics of steroid-induced ocular hypertension in children receiving systemic glucocorticoid therapy.
- To identify potential risk factors associated with this adverse effect.
Main Methods:
- A prospective cohort study involving children treated with high-dose systemic glucocorticoids (>0.5 mg/kg/day prednisolone equivalent) for over two weeks.
- Intraocular pressure (IOP) was measured using an Icare tonometer.
- Ocular hypertensive response defined as a net increase in IOP ≥6 mmHg or peak IOP ≥21 mmHg.
Main Results:
- 56% of the 16 children studied developed a steroid-induced ocular hypertensive response.
- 12% were classified as high responders with significant IOP elevations.
- Younger children were more likely to be steroid responders (p=0.03).
- No correlation found between IOP increase and steroid dosage or duration.
Conclusions:
- Systemic glucocorticoid therapy in children poses a significant risk of elevated intraocular pressure.
- Regular intraocular pressure screening is essential for children undergoing such treatments.
- Age appears to be a significant factor, with younger children being more susceptible; further research into ethnic variations is warranted.
Purpose:
To investigate the risk of steroid-induced ocular hypertension in children treated with systemic glucocorticoid.
Methods:
Prospective cohort study of children treated with high-dose systemic glucocorticoid (prednisolone-equivalent >0.5 mg/kg/day) for more than 2 weeks. Intraocular pressure (IOP) was measured by an Icare tonometer. An intraocular hypertensive response was defined as a net increase in IOP ≥6 mmHg from baseline or a peak IOP ≥21 mmHg in either eye. Patients with a peak IOP ≥31 mmHg or a net increase in IOP ≥15 mmHg were considered as high responders.
Results:
Sixteen children with median age 12 years (range 5-17) were included in the study. Nine children (56%) developed a steroid-induced ocular hypertensive response. Two children (12%) were high responders with peak IOP between 32 and 44 mmHg and a net increase in IOP between 15 and 23 mmHg. All children were asymptomatic and IOP was normalized in all after withdrawal of steroid. Steroid responders were significantly younger than nonresponders (p = 0.03). No associations were found between net IOP increase and time to peak pressure, steroid dose at peak pressure or accumulated prednisolone dose at peak IOP.
Conclusion:
Systemic treatment of children with glucocorticoid can cause a significant increase in IOP which indicates the need for IOP screening of these children. The risk of steroid-induced ocular hypertension may depend on age and ethnicity. In this perspective, further studies on Caucasian children are needed.
More Related Videos
10:10Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
08:55Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Accessory Structures of the Eye
Hypertension III: Clinical Manifestations and Diagnostic Studies